Literature DB >> 23543085

Association study of genetic variants in miRNAs in patients with inflammatory bowel disease: preliminary results.

Maria Gazouli1, Ioannis Papaconstantinou, Konstantinos Stamatis, Anna Vaiopoulou, Christos Zeglinas, Ioannis Vassiliou, Georgios Giokas, Charalampos Tzathas.   

Abstract

BACKGROUND: Aberrant expression and structural alteration of miRNAs are considered to participate in inflammation and cancer development. It has been suggested that common single-nucleotide polymorphisms (SNPs) in miRNAs are associated with susceptibility to several human diseases.
METHODS: In the present preliminary study we evaluated the associations of two SNPs (rs2910164 and rs11614913 in miR-146a and miR-196a2, respectively) with the risk of inflammatory bowel disease (IBD) in a Greek population.
RESULTS: The rs2910164 and rs11614913 SNPs were genotyped in 242 patients with Crohn's disease (CD), 210 patients with ulcerative colitis (UC) and 300 healthy individuals. No statistically significant differences were found in the genotype or allele distributions of the rs2910164 SNP among UC and control subjects. However, significant differences were found in the genotype or allele distributions of the rs2910164 polymorphism among CD and control subjects (P < 0.0001 and P < 0.0001, respectively). Concerning the rs11614913, no statistically significant differences were found in the genotype or allele distributions among CD and control patients, whereas TT genotype and T allele seem to have a protective role against UC (P = 0.017 and P = 0.007, respectively). The presence of rs2910164 and rs11614913 SNPs did not influence disease phenotype.
CONCLUSIONS: Our results demonstrate that the rs2910164 polymorphism has a major role in genetic susceptibility to CD but not to UC, since the rs11614913 polymorphism had a protective role against UC, at least in the population studied here. Independent studies are needed to validate our findings in larger series and in patients of different ethnic origins.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23543085     DOI: 10.1007/s10620-013-2640-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  40 in total

1.  Associations of miRNA polymorphisms and female physiological characteristics with breast cancer risk in Chinese population.

Authors:  M Zhang; M Jin; Y Yu; S Zhang; Y Wu; H Liu; H Liu; B Chen; Q Li; X Ma; K Chen
Journal:  Eur J Cancer Care (Engl)       Date:  2011-11-11       Impact factor: 2.520

2.  Single nucleotide polymorphism in hsa-mir-196a-2 and breast cancer risk: a case control study.

Authors:  Dominik J Jedlinski; Plamena N Gabrovska; Stephen R Weinstein; Robert A Smith; Lyn R Griffiths
Journal:  Twin Res Hum Genet       Date:  2011-10       Impact factor: 1.587

3.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

4.  A functional polymorphism in Pre-miR-146a is associated with susceptibility to gastric cancer in a Chinese population.

Authors:  Fengying Zhou; Haixia Zhu; Dewei Luo; Meilin Wang; Xiao Dong; Yan Hong; Bo Lu; Yan Zhou; Jianwei Zhou; Zhengdong Zhang; Weida Gong
Journal:  DNA Cell Biol       Date:  2012-03-28       Impact factor: 3.311

5.  Evaluation of SNPs in miR-196-a2, miR-27a and miR-146a as risk factors of colorectal cancer.

Authors:  Renata Hezova; Alena Kovarikova; Julie Bienertova-Vasku; Milana Sachlova; Martina Redova; Anna Vasku; Marek Svoboda; Lenka Radova; Igor Kiss; Rostislav Vyzula; Ondrej Slaby
Journal:  World J Gastroenterol       Date:  2012-06-14       Impact factor: 5.742

6.  Identification of microRNAs associated with ileal and colonic Crohn's disease.

Authors:  Feng Wu; Simin Zhang; Themistocles Dassopoulos; Mary L Harris; Theodore M Bayless; Stephen J Meltzer; Steven R Brant; John H Kwon
Journal:  Inflamm Bowel Dis       Date:  2010-10       Impact factor: 5.325

7.  Circulating microRNA is a biomarker of pediatric Crohn disease.

Authors:  Adam M Zahm; Meena Thayu; Nicholas J Hand; Amber Horner; Mary B Leonard; Joshua R Friedman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-07       Impact factor: 2.839

Review 8.  Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics.

Authors:  F Shanahan
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

9.  A genetic variant in miR-196a2 increased digestive system cancer risks: a meta-analysis of 15 case-control studies.

Authors:  Jing Guo; Mingjuan Jin; Mingwu Zhang; Kun Chen
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240

10.  Impacts of microRNA gene polymorphisms on the susceptibility of environmental factors leading to carcinogenesis in oral cancer.

Authors:  Yin-Hung Chu; Shu-Ling Tzeng; Chiao-Wen Lin; Ming-Hsien Chien; Mu-Kuan Chen; Shun-Fa Yang
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

View more
  18 in total

Review 1.  MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases.

Authors:  Sara De Iudicibus; Marianna Lucafò; Stefano Martelossi; Chiara Pierobon; Alessandro Ventura; Giuliana Decorti
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

2.  Polymorphisms in MIR122, MIR196A2, and MIR124A Genes are Associated with Clinical Phenotypes in Inflammatory Bowel Diseases.

Authors:  Cinzia Ciccacci; Cristina Politi; Livia Biancone; Andrea Latini; Giuseppe Novelli; Emma Calabrese; Paola Borgiani
Journal:  Mol Diagn Ther       Date:  2017-02       Impact factor: 4.074

Review 3.  Polymorphisms in miRNA genes and their involvement in autoimmune diseases susceptibility.

Authors:  Andrea Latini; Cinzia Ciccacci; Giuseppe Novelli; Paola Borgiani
Journal:  Immunol Res       Date:  2017-08       Impact factor: 2.829

Review 4.  Role of MiRNAs in Inflammatory Bowel Disease.

Authors:  Bo Cao; Xin Zhou; Jiaojiao Ma; Wei Zhou; Wanli Yang; Daiming Fan; Liu Hong
Journal:  Dig Dis Sci       Date:  2017-04-08       Impact factor: 3.199

5.  Association of miR-146a rs2910164 with childhood IgA nephropathy.

Authors:  Junhong Lin; Yao Huang; Xuelin Zhang; Junbin Chen; Haihui Sheng
Journal:  Pediatr Nephrol       Date:  2014-04-30       Impact factor: 3.714

6.  Meta-analysis of microRNA-146a rs2910164 G>C polymorphism association with autoimmune diseases susceptibility, an update based on 24 studies.

Authors:  Changzheng Li; Weijun Fu; Yu Zhang; Liang Zhou; Zhi Mao; Weiran Lv; Juan Li; Ye Zhou
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

Review 7.  MicroRNAs and the regulation of intestinal homeostasis.

Authors:  Marah C Runtsch; June L Round; Ryan M O'Connell
Journal:  Front Genet       Date:  2014-10-01       Impact factor: 4.599

Review 8.  Small and Long Regulatory RNAs in the Immune System and Immune Diseases.

Authors:  Anna Stachurska; Maria M Zorro; Marijke R van der Sijde; Sebo Withoff
Journal:  Front Immunol       Date:  2014-10-20       Impact factor: 7.561

9.  RNASEL and MIR146A SNP-SNP interaction as a susceptibility factor for non-melanoma skin cancer.

Authors:  Shohreh F Farzan; Margaret R Karagas; Brock C Christensen; Zhongze Li; Jacquelyn K Kuriger; Heather H Nelson
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

10.  A single-nucleotide polymorphism of miR-146a and psoriasis: an association and functional study.

Authors:  Weigang Zhang; Xiuli Yi; Sen Guo; Qiong Shi; Chao Wei; Xia Li; Lin Gao; Gang Wang; Tianwen Gao; Lei Wang; Chunying Li
Journal:  J Cell Mol Med       Date:  2014-09-11       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.